Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS)
| Autor: | Simron Singh, Jonathan R. Strosberg, David C. Metz, Nick Pavlakis, Lesley Moody, Eva Segelov, David Chan |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Endocrinology Diabetes and Metabolism Steering committee Guidelines as Topic 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Endocrinology Stomach Neoplasms Internal medicine Surveys and Questionnaires Health care Intestinal Neoplasms medicine Humans Practice Patterns Physicians' Endocrine and Autonomic Systems business.industry International survey Neuroendocrine tumour Pancreatic Neoplasms Neuroendocrine Tumors 030104 developmental biology 030220 oncology & carcinogenesis Family medicine Commonwealth Guideline Adherence business |
| Zdroj: | Neuroendocrinology. 107(1) |
| ISSN: | 1423-0194 |
| Popis: | Objectives: There is no consensus regarding optimal follow-up in resected gastroenteropancreatic neuroendocrine tumours (NETs). We aimed to perform a practice survey to ascertain follow-up patterns by health care practitioners and highlight areas of variation that may benefit from further quantitative research. Methods: A Web-based survey targeted at NET health care providers in Australia, New Zealand, Canada, and the USA was developed by a steering committee of medical oncologists and a research methodologist. Thirty-seven questions elicited information regarding adherence to guidelines, the influence of risk factors on follow-up, and the frequency and choice of modality in follow-up. Results: There were 163 respondents: 59 from Australia, 25 from New Zealand, 46 from Canada, and 33 from the USA (50% medical oncology, 23% surgery, 13% nuclear medicine, and 15% other). Thirty-eight percent of the respondents were “very familiar” with the NCCN NET guidelines, 33% with the ENETS guidelines, and 17% with the ESMO guidelines; however, only 15, 27, and 10%, respectively, found them “very useful”; 63% reported not using guidelines at their institution. The commonest investigations used were CT scans (66%) and chromogranin A (86%). The US respondents were more likely to follow patients up past 5 years, and the Australian respondents utilized more functional and less cross-sectional imaging. When poor prognostic factors were introduced, the respondents recommended more visits and tests. Conclusions: This large international survey highlights variation in current follow-up practices not well addressed by the current guidelines. More quantitative research is required to inform the development of evidence-based guidelines tailored to the pattern of recurrence in NETs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|